These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36334265)

  • 1. Elucidating the neurological mechanism of the FLASH effect in juvenile mice exposed to hypofractionated radiotherapy.
    Allen BD; Alaghband Y; Kramár EA; Ru N; Petit B; Grilj V; Petronek MS; Pulliam CF; Kim RY; Doan NL; Baulch JE; Wood MA; Bailat C; Spitz DR; Vozenin MC; Limoli CL
    Neuro Oncol; 2023 May; 25(5):927-939. PubMed ID: 36334265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy.
    Alaghband Y; Allen BD; Kramár EA; Zhang R; Drayson OGG; Ru N; Petit B; Almeida A; Doan NL; Wood MA; Baulch JE; Ballesteros-Zebadua P; Vozenin MC; Limoli CL
    Cancer Res Commun; 2023 Apr; 3(4):725-737. PubMed ID: 37377749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection of Radiosensitive Juvenile Mice by Ultra-High Dose Rate FLASH Irradiation.
    Alaghband Y; Cheeks SN; Allen BD; Montay-Gruel P; Doan NL; Petit B; Jorge PG; Giedzinski E; Acharya MM; Vozenin MC; Limoli CL
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32599789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.
    Montay-Gruel P; Acharya MM; Gonçalves Jorge P; Petit B; Petridis IG; Fuchs P; Leavitt R; Petersson K; Gondré M; Ollivier J; Moeckli R; Bochud F; Bailat C; Bourhis J; Germond JF; Limoli CL; Vozenin MC
    Clin Cancer Res; 2021 Feb; 27(3):775-784. PubMed ID: 33060122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance of Tight Junction Integrity in the Absence of Vascular Dilation in the Brain of Mice Exposed to Ultra-High-Dose-Rate FLASH Irradiation.
    Allen BD; Acharya MM; Montay-Gruel P; Jorge PG; Bailat C; Petit B; Vozenin MC; Limoli C
    Radiat Res; 2020 Dec; 194(6):625-635. PubMed ID: 33348373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.
    Almeida A; Godfroid C; Leavitt RJ; Montay-Gruel P; Petit B; Romero J; Ollivier J; Meziani L; Sprengers K; Paisley R; Grilj V; Limoli CL; Romero P; Vozenin MC
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):1110-1122. PubMed ID: 37951550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma.
    Liljedahl E; Konradsson E; Gustafsson E; Jonsson KF; Olofsson JK; Ceberg C; Redebrandt HN
    Sci Rep; 2022 Jul; 12(1):12285. PubMed ID: 35853933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-High-Dose-Rate FLASH Irradiation Limits Reactive Gliosis in the Brain.
    Montay-Gruel P; Markarian M; Allen BD; Baddour JD; Giedzinski E; Jorge PG; Petit B; Bailat C; Vozenin MC; Limoli C; Acharya MM
    Radiat Res; 2020 Dec; 194(6):636-645. PubMed ID: 32853387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Deep Learning for Estimating the Isoeffective Dose of FLASH Irradiation From Mouse Intestinal Histological Images.
    Fu J; Yang Z; Melemenidis S; Viswanathan V; Dutt S; Manjappa R; Lau B; Soto LA; Ashraf MR; Skinner L; Yu SJ; Surucu M; Casey KM; Rankin EB; Graves E; Lu W; Loo BW; Gu X
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1001-1010. PubMed ID: 38171387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Advantage of FLASH Radiotherapy Confirmed in Mini-pig and Cat-cancer Patients.
    Vozenin MC; De Fornel P; Petersson K; Favaudon V; Jaccard M; Germond JF; Petit B; Burki M; Ferrand G; Patin D; Bouchaab H; Ozsahin M; Bochud F; Bailat C; Devauchelle P; Bourhis J
    Clin Cancer Res; 2019 Jan; 25(1):35-42. PubMed ID: 29875213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies.
    Zhu H; Xie D; Wang Y; Huang R; Chen X; Yang Y; Wang B; Peng Y; Wang J; Xiao D; Wu D; Qian CN; Deng X
    Clin Transl Radiat Oncol; 2023 Jan; 38():138-146. PubMed ID: 36425537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.
    Montay-Gruel P; Acharya MM; Petersson K; Alikhani L; Yakkala C; Allen BD; Ollivier J; Petit B; Jorge PG; Syage AR; Nguyen TA; Baddour AAD; Lu C; Singh P; Moeckli R; Bochud F; Germond JF; Froidevaux P; Bailat C; Bourhis J; Vozenin MC; Limoli CL
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10943-10951. PubMed ID: 31097580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy.
    Liljedahl E; Konradsson E; Linderfalk K; Gustafsson E; Petersson K; Ceberg C; Redebrandt HN
    Front Oncol; 2023; 13():1309174. PubMed ID: 38322292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma.
    Padilla O; Minns HE; Wei HJ; Fan W; Webster-Carrion A; Tazhibi M; McQuillan NM; Zhang X; Gallitto M; Yeh R; Zhang Z; Hei TK; Szalontay L; Pavisic J; Tan Y; Deoli N; Garty G; Garvin JH; Canoll PD; Vanpouille-Box C; Menon V; Olah M; Rabadan R; Wu CC; Gartrell RD
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1248-1260. PubMed ID: 38364947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-high-dose-rate FLASH and Conventional-Dose-Rate Irradiation Differentially Affect Human Acute Lymphoblastic Leukemia and Normal Hematopoiesis.
    Chabi S; To THV; Leavitt R; Poglio S; Jorge PG; Jaccard M; Petersson K; Petit B; Roméo PH; Pflumio F; Vozenin MC; Uzan B
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):819-829. PubMed ID: 33075474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
    Kinj R; Gaide O; Jeanneret-Sozzi W; Dafni U; Viguet-Carrin S; Sagittario E; Kypriotou M; Chenal J; Duclos F; Hebeisen M; Falco T; Geyer R; Gonçalves Jorge P; Moeckli R; Bourhis J
    Clin Transl Radiat Oncol; 2024 Mar; 45():100743. PubMed ID: 38362466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model.
    Konradsson E; Liljedahl E; Gustafsson E; Adrian G; Beyer S; Ilaahi SE; Petersson K; Ceberg C; Nittby Redebrandt H
    Adv Radiat Oncol; 2022; 7(6):101011. PubMed ID: 36092986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLASH Effects Induced by Orthovoltage X-Rays.
    Miles D; Sforza D; Wong JW; Gabrielson K; Aziz K; Mahesh M; Coulter JB; Siddiqui I; Tran PT; Viswanathan AN; Rezaee M
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):1018-1027. PubMed ID: 37364800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous dose and dose rate optimization (SDDRO) of the FLASH effect for pencil-beam-scanning proton therapy.
    Gao H; Liu J; Lin Y; Gan GN; Pratx G; Wang F; Langen K; Bradley JD; Rotondo RL; Li HH; Chen RC
    Med Phys; 2022 Mar; 49(3):2014-2025. PubMed ID: 34800301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.